For IDH immunohistochemistry results, we noted that IDH partially positive glioma had SDC values lying between those of IDH mutant negative gliomas and IDH mutant negative gliomas (Figure-4 C), suggesting an intermediate cellular density and corresponding histopathological profile. The gene discussed is IDH2; the disease is central nervous system cancer.